SOURCES SOUGHT
A -- Phase III Efficacy Trial of Pneumococcal Conjugate Vaccine in The Gambia
- Notice Date
- 5/16/2002
- Notice Type
- Sources Sought
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institutes of Allergy and Infectious Diseases, Contract Management Branch 6700-B Rockledge Drive, MSC 7612 Room 2230, Bethesda, MD, 20892-7612
- ZIP Code
- 20892-7612
- Solicitation Number
- Reference-Number-Gambia02
- Response Due
- 6/30/2002
- Archive Date
- 7/15/2002
- Point of Contact
- Thomas Hastings, Contracting Officer, Phone 301-496-0194, Fax 301-402-0972, - Lawrence Butler, Contracting Officer, Phone 301-496-0192, Fax 301-402-0972,
- E-Mail Address
-
ph23k@nih.gov, lb13t@nih.gov
- Description
- The National Institute of Allergy and Infectious Diseases intends to negotiate for a 3-year contract with the Medical Research Council (MRC) of Great Britain. The nature of the work is to complete a Phase III trial to evaluate the efficacy of a 9-valent pneumococcal conjugate vaccine in a pediatric population in the Upper River and Central River regions of The Gambia, West Africa. This contract will provide information and support for the completion of the trial, which was implemented in July, 2000 in collaboration with the NIAID/NIH, USAID, WHO, the Gates Foundation, and the MRC. The contractor is uniquely qualified to complete the trial, which has enrolled approximately 8,000 patients. This contract will permit continued access to a population at high risk for developing pneumonia within the first two years of life. Inherent duplication of cost to the Government and unacceptable delays in completing the project make competition unfeasible for the conduct and completion of this clinical trial. Authority 41 U.S.C. 253(c)(1) as set forth in FAR 6.302-1.
- Record
- SN00078146-W 20020518/020516213105 (fbodaily.com)
- Source
-
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |